endothelial-dysfunction

Documents about endothelial-dysfunction

• Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries#906678ClinicalTrials.gov
• Pathophysiology-guided biomarkers and therapeutics for precision trauma medicine in polytrauma with musculoskeletal injuries#4480Europe PMC
• The Endocrine Axis of Fragilysin: Colonic E-Cadherin Shedding as a Systemic Heterophilic Decoy Driving Endothelial Dysfunction and Plaque Vulnerability#233247OSF
• Multi-omics biomarkers of endothelial dysregulation preceding chronic lung allograft dysfunction: A prospective cohort study#305593PLOS
• Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome#803385ClinicalTrials.gov
• Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial#855054ClinicalTrials.gov
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor#861411ClinicalTrials.gov
• IMPACT OF DIFFERENT QUANTITY AND SOURCE OF DIETARY PROTEIN INTAKE ON CARDIOVASCULAR DISEASE RISK FACTORS#264977ScholarBank@NUS
• Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.#855814ClinicalTrials.gov
• NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy#871055ClinicalTrials.gov
• The Effect of a Diabetic- and a Kidney-like Environment on Gene and Protein Expression in Cultured EC and SMC#879498ClinicalTrials.gov
• Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults#883872ClinicalTrials.gov
• Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.#876662ClinicalTrials.gov
• PATHOGENESIS OF ARTERIAL HYPERTENSION AND IMPAIRMENT OF PHYSIOLOGICAL REGULATION#166628Zenodo (CERN)
• Effects of an Indoor Cycling Program on Cardio-Metabolic Factors in Women With Obesity and Normal Body Weight#226135ClinicalTrials.gov
• Ranolazine Is Associated with Attenuation of Lipopolysaccharide-Induced Acute Kidney Injury via Modulation of Inflammatory, Oxidative, and Vascular Markers#376907İzmir Yüksek Teknoloji Enstitüsü
• Beyond hypertension: current concepts in postpartum posterior reversible encephalopathy syndrome - a narrative review#481476ARPHA OAI-PMH Endpoint
• Endothelial Cell Dysfunction in Pulmonary Hypertension#882348ClinicalTrials.gov
• Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes#904466ClinicalTrials.gov
• Publisher Correction: Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients (Scientific Reports, (2021), 11, 1, (10604), 10.1038/s41598-021-89834-9)#948513Repositorio de Universidad Autónoma de Chile.
• Effect of Non-alcoholic Beer in Cirrhosis#1008101ClinicalTrials.gov
• Characterization of the microVAScular Dysfunction in Covid-19 ARDS#881010ClinicalTrials.gov
• Effects of Nitrate-rich Beetroot Juice in Pregnant Women With High Blood Pressure#906891ClinicalTrials.gov
• Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid#1046323ClinicalTrials.gov
• Role of Constitutive Endothelial Dysfunction in the Pathogenesis of Unprovoked Venous Thromboembolism: Characterization of Endothelial Colony-Forming Cells and Association with Risk of Recurrence#478765IRIS
• Systemic Arterial Stiffness in Reversible Cerebral Vasoconstriction Syndrome: A Prospective Case–Control Study#129407HAL (France)
• Downregulation of low-density lipoprotein receptor mRNA in lymphatic endothelial cells impairs lymphatic function through changes in intracellular lipids#268576HAL (France)
• The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome#850928ClinicalTrials.gov
• Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock#859508ClinicalTrials.gov
• Acute Responses to Arm-Crank Exercise on Cardiovascular Function of Patients With Peripheral Artery Disease#908116ClinicalTrials.gov
• PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)#967284ClinicalTrials.gov
• A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases#683005ClinicalTrials.gov
• Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation#826675ClinicalTrials.gov
• A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease#835872ClinicalTrials.gov
• C-C chemokine ligand 5 from women subcutaneous adipose tissue has a central role in vascular aging#126770HAL (France)
• Effect of Aged Garlic Extract (AGE) on Improving Coronary Atherosclerosis in People With Type 2 Diabetes Mellitus#674848ClinicalTrials.gov
• Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient#893341ClinicalTrials.gov
• Bioinformatics and experimental studies of atherosclerosis-related endothelial dysfunction genes in renal calculi and exploration of their molecular mechanisms#428178PLOS
• The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies#875970ClinicalTrials.gov
• All Eyes on PCS - Analysis of the Retinal Microvasculature in Patients With Post-COVID-19 Syndrome#896860ClinicalTrials.gov
• Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction#1030573ClinicalTrials.gov
• MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes#329494ClinicalTrials.gov
• Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV#1033165ClinicalTrials.gov
• Mothers against decapentaplegic homolog 4 as a proteomic hub in vascular remodeling and residual cardiovascular risk#185404IRIS
• Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients#805580ClinicalTrials.gov
• Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes#125983ClinicalTrials.gov
• Study to Monitor the Effects of Androgen Suppression Treatment on the Heart#846045ClinicalTrials.gov
• Mechanism-Driven Therapy for Diabetic Cardiovascular Disease#477034ODU Digital Commons
• Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea#1046229ClinicalTrials.gov
• Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes#373751ClinicalTrials.gov